Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health Strategy
Clinical Transplantation · 2025-10 · 39 (10)
DOI: 10.1111/ctr.70346 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Transplantation, online erschienen am 15.10.2025. Verfasst von Hildegard T Greinix und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Bone Marrow Transplantation, Medical University Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Global Health, Organ Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Allogeneic hematopoietic cell transplantation (HCT) and solid organ transplantation (SOT) have evolved into successful, curative treatments for many severe congenital and acquired diseases. Both use medical products of human origin and should therefore have overarching regulatory frameworks. Both require critical decisions about donor selection, donor/recipient matching, immunosuppression, and long‐term care, all tasks best performed by a trained, highly specialized multidisciplinary team. Both need committed institutions and governmental support for their success. Whereas the main barrier for performing SOT is the lack of suitable organs, access to a transplant center is the main limitation for HCT, which remains a highly specialized, complex, resource‐intensive, and costly medical procedure. Methods and Results Here, we describe the main indications for HCT and SOT, their similarities and differences regarding donor selection, treatment prior to transplant, intensity and duration of immunosuppression after transplantation, their main complications, and consequences of donation for living donors.
Conclusions
Strategies to improve worldwide access to HCT and SOT are discussed, as well as future developments in this highly innovative field of medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Bone Marrow Transplantation, Medical University Vienna, Vienna, Austria.
- University of Minnesota Medical School, Minneapolis, USA.
- Infection and Immunity Group, City St George's, Department of Haematology, St George's University Hospitals, University of London, London, UK.
- WMDA (World Marrow Donor Association), Leiden, the Netherlands.
- Department of Transfusion Medicine and Cell Therapy, Medical University Vienna, Vienna, Austria.
- Divsion of Nephrology, Department of Medicine, Nova Scotia Health; Kidney Research Institute Nova Scotia, Nova Scotia, Canada.
ORCID-Profile: Hildegard T Greinix, Arthur Matas, Daniel Weisdorf
Zitieren
APA
Greinix, H. T., Matas, A., Koh, M. B. C., Foeken, L., Worel, N., Vinson, A., Ibrahim, H., Sawinski, D., Seber, A., Valapour, M., Atsuta, Y., Mengling, T., Lake, J., Wekerle, T., & Weisdorf, D. (2025). Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health Strategy. Clinical Transplantation, 39(10). https://doi.org/10.1111/ctr.70346
Vancouver
Greinix HT, Matas A, Koh MBC, Foeken L, Worel N, Vinson A, et al. Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health Strategy. Clinical Transplantation. 2025;39(10). doi:10.1111/ctr.70346
BibTeX
@article{Greinix2025,
author = {Greinix, Hildegard T and Matas, Arthur and Koh, Mickey B C and Foeken, Lydia and Worel, Nina and Vinson, Amanda and Ibrahim, Hassan and Sawinski, Deirdre and Seber, Adriana and Valapour, Maryam and Atsuta, Yoshiko and Mengling, Thilo and Lake, John and Wekerle, Thomas and Weisdorf, Daniel},
title = {Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health Strategy},
journal = {Clinical Transplantation},
year = {2025},
volume = {39},
number = {10},
doi = {10.1111/ctr.70346}
}
EUVIMED